Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

OBJECTIVE: To compare rates of performing National Institute for Health and Care Excellence-recommended health checks and prescribing in people with type 2 diabetes (T2D), before and after the first COVID-19 peak in March 2020, and to assess whether trends varied by age, sex, ethnicity and deprivati...

Full description

Bibliographic Details
Main Authors: Ashcroft, D.M (Author), Carr, M.J (Author), Kanumilli, N. (Author), Leelarathna, L. (Author), Milne, N. (Author), Rutter, M.K (Author), Thabit, H. (Author), Wright, A.K (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
aged
Aged
antihypertensive agent
Antihypertensive Agents
cohort analysis
Cohort Studies
COVID-19
diabetes mellitus
Diabetes Mellitus, Type 2
England
epidemiology
health services research
human
Humans
lipid
Lipids
non insulin dependent diabetes mellitus
primary care
primary health care
Primary Health Care
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items